Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raynaud's Phenomenon Secondary to Connective Tissue Disease”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Early research (Phase 1)Study completedNCT00700518
What this trial is testing

Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Procris Pharmaceuticals 10
Not applicableUnknownNCT01378845
What this trial is testing

Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands

Who this might be right for
Raynaud's PhenomenonSkin Necrosis
Christoph Hehrlein 30
Testing effectiveness (Phase 2)Study completedNCT02688270
What this trial is testing

Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon Secondary to Connective Tissue Disease
Covis Pharma S.à.r.l. 65
Large-scale testing (Phase 3)Study completedNCT00266669
What this trial is testing

Phase III Study of Topical Gel for Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 200
Not applicableStudy completedNCT02202291
What this trial is testing

Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon

Who this might be right for
Primary Raynaud's Phenomenon (PR)Genetic Mutations Causing PRStudy of Patients and Their Relatives (With or Without Primary PR)
Nantes University Hospital 258
Not applicableUnknownNCT02183779
What this trial is testing

PORH and Response to Cold in Raynaud's Phenomenon.

Who this might be right for
Raynaud DiseaseHyperemiaCold
University Hospital, Grenoble 60
Very early researchStudy completedNCT02583789
What this trial is testing

Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
Brigham and Women's Hospital 12
Post-approval studies (Phase 4)Looking for participantsNCT07112183
What this trial is testing

Open Label Treprostinil Raynaud's Study

Who this might be right for
Raynaud's DiseaseRaynaud PhenomenaRaynauds
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01926847
What this trial is testing

Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator

Who this might be right for
Raynaud Disease
Bayer 23
Testing effectiveness (Phase 2)Study completedNCT02228850
What this trial is testing

Study of Acute Peripheral Vascular Effects, Safety and Tolerability in Subjects With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
NexMed (U.S.A.), Inc. (subsidiary of Apricus Biosciences, Inc.) 35
Large-scale testing (Phase 3)Study completedNCT03717961
What this trial is testing

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 91
Testing effectiveness (Phase 2)Study completedNCT04744207
What this trial is testing

Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Gesynta Pharma AB 94
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748000
What this trial is testing

LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Liquidia Technologies, Inc. 75
Not applicableUnknownNCT03749577
What this trial is testing

Nutritional Strategies to Increase Nitric Oxide Signaling in Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University Hospital, Grenoble 30
Testing effectiveness (Phase 2)Study completedNCT04388176
What this trial is testing

Cold Challenge With C21 in RP

Who this might be right for
Raynaud PhenomenonSystemic Sclerosis
Vicore Pharma AB 20
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT02260557
What this trial is testing

Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Actelion 74
Not applicableStudy completedNCT00822354
What this trial is testing

Tadalafil for the Treatment of Raynaud's

Who this might be right for
Raynaud
Northwestern University 10
Testing effectiveness (Phase 2)Study completedNCT03867097
What this trial is testing

Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2)

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Civi Biopharma, Inc. 34
Large-scale testing (Phase 3)Study completedNCT02050360
What this trial is testing

"As Required" Oral Sildenafil in Raynaud's Phenomenon

Who this might be right for
Raynaud's Phenomenon
University Hospital, Grenoble 41
Next Page